New Data Published from Women & Infants Hospital Demonstrate Utility of Predictive Immune Modeling in Ovarian Cancer
PROVIDENCE, R.I. – March 8, 2021 – Cofactor Genomics, the company bridging the precision medicine gap, announced today new data published in Frontiers in Oncology1 by Women & Infants Hospital of Rhode Island. The data highlight the utility of Cofactor’s Predictive Immune Model...
UCSD Partners with Cofactor Genomics to Improve Patient Outcomes in Metastatic Head and Neck Cancer
SAN DIEGO, Calif.– SEPTEMBER 15, 2020 – Physicians at the University of California, San Diego (UCSD) School of Medicine and Cofactor Genomics, the company bridging the precision medicine gap, today announced a partnership aimed at improving a physician’s ability to predict tum...
Cofactor Genomics Announces New U.S. Patent Granted for Predictive Immune Modeling Technology
SAN FRANCISCO, Calif. – August 20, 2020 – Cofactor Genomics, the company bridging the precision medicine gap, announced today that the United States Patent and Trademark Office (USPTO) has granted Patent No. 10636512 protecting the Company’s predictive immune modeling technolo...